The late-night surge in Bionano Genomics, Inc. (Nasdaq: BNGO) shares reflects this factor

ASTR Stock
ASTR Stock

Bionano Genomics, Inc. (Nasdaq: BNGO), shares surged 30.08% to $1.73 in the late hours trading session after on December 28, 2020, Bionano Genomics, Inc. (Nasdaq: BNGO), revealed that Praxis Genomics, LLC had been accredited by the College of American Pathologists (CAP), becoming the first CAP-accredited, CLIA-certified diagnostic lab in the U.S. to offer a whole genome testing method with Saphyr.This test is designed to evaluate postnatal patients for constitutional genetic disorders.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Praxis uses optical genome mapping with the Bionano Saphyr Framework as an option in contrast chromosomal microarray and caryotyping approaches (KT), as they are trying to increase the rate of clinical diagnosis for genetic disorder patients.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Read More

Hence, doctors recommend that sequential rounds of analysis are performed using CMA, KT, repeat expansion testing, and exome sequencing until a pathogenic variant has been identified.

This tiered approach is replaced at Praxis with whole genome analysis using OGM with Saphyr for structural variants (SVs) and next-generation sequencing (NGS) for SNVs.


Please enter your comment!
Please enter your name here